arrow
C

Christine E. Brown

city of hope beckman research institute and medical center
H指数:65
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2026-09-240
PRE
A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm

靶向CD123的嵌合抗原受体T细胞疗法在复发/难治性急性髓系白血病或 blasti c plasmacytoid dendritic cell neoplasm 成人中的1期临床试验

2026-08-070
OA
Whole-protein screening and multi-modal profiling of antigen-specific CD4+ T cells at single-cell resolution

全蛋白质筛选和多模态分析抗原特异性CD4+ T细胞在单细胞分辨率

2026-05-120
OAAI
Foundation Model Cascades Enable Zero-Shot Microscopy Image Analysis for Cell Therapy Manufacturing

Foundation Model Cascades支持细胞疗法制造的零拍显微镜图像分析

2026-02-030
OAAI
Label-free in-line characterization of immune cell culture using quantitative phase imaging

基于定量相位成像的免疫细胞培养物无标记在线表征

2025-11-270
OAAI
CTIM-07. A PHASE 1 STUDY OF INTRAVENTRICULARLY ADMINISTERED AUTOLOGOUS HER2-TARGETING CHIMERIC ANTIGEN RECEPTOR T CELLS (HER2-CAR T CELLS), WITH AND WITHOUT LYMPHODEPLETION, IN HER2-POSITIVE BREAST CANCER PATIENTS WITH RECURRENT BRAIN AND/OR LEPTOMENINGEAL METASTASES

CTIM-07。一项I期研究,评估经脑室内给药的自体HER2靶向嵌合抗原受体T细胞(HER2-CAR T细胞),在伴或不伴淋巴细胞清除的情况下,用于HER2阳性乳腺癌患者复发脑和/或软脑膜转移的疗效。

2025-11-110
OA
Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic

使用deepsmatoma实现多种测序技术的准确体细胞小变异发现

2025-10-160
PRE
CAR T-cell and oncolytic virus dynamics and determinants of combination therapy success for glioblastoma

Conte, M.; Xella, A.; Woodall, R.T.; Cassady, K.A.; Branciamore, S.; Brown, C.E.; Rockne, R.C. CAR T细胞和溶瘤病毒动力学及胶质母细胞瘤联合治疗成功的决定因素。Math. Biosci. 2025, 389, 109531. [Google Scholar] [CrossRef]

2025-09-012
OAAI
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety

氯毒素靶向的CAR T细胞疗法治疗复发性胶质母细胞瘤:中期临床经验表明其可行性和安全性

2025-08-150
PREAI
CONQUERING SPP1+MYELOID-DRIVEN RESISTANCE OF GLIOBLASTOMA TO IL13RA2-TARGETED CAR T CELL THERAPY
2024-11-110
PRE